Palmer Luckey Plans Offshore Haven for Industry and 'Illegal' Medicine
Published
Palmer Luckey, the billionaire founder of virtual reality headset maker Oculus and defense technology firm Anduril, is reportedly investing over $1 billion in a private island concept designed to operate beyond the reach of U.S.
MissedBlock Desk · 4 min read
Palmer Luckey, the billionaire founder of virtual reality headset maker Oculus and defense technology firm Anduril, is reportedly investing over $1 billion in a private island concept designed to operate beyond the reach of U.S. laws.
The ambitious project, dubbed SLAB, envisions a massive industrial platform situated in the ocean, intended to host American businesses free from certain land-based regulations. Luckey has apparently been developing this idea for nearly a decade.
A Vision for Offshore Industry
In an X post published Wednesday, Luckey unveiled SLAB as a proposed seastead with a 1,000-year design life. He claims it could accommodate a wide range of industries, from metal processing and oil refining to medical research and treatment.
Luckey stated his objective is to establish an industrial base that is more cost-effective than land-based operations and unburdened by state and local laws he believes hinder critical American industries. He characterized the project not as an escape from the U.S., but as a means to strengthen the nation by acting as a “relief valve” for outdated regulations.
“Me and a few close friends cashed it up at a $1B valuation back in 2017, and while it still has a long way to go, there has been significant progress towards my goal of reviving manifest destiny and westward expansion,” he wrote in his post.
Luckey indicated that proceeds from Facebook’s 2014 acquisition of Oculus were used to fund the project. The announcement was accompanied by an AI-generated illustration of a vast offshore platform, rather than images of an operational facility, making it difficult to ascertain the current stage of the endeavor.
Clarifying the Project’s Scope
Luckey decided to disclose details about SLAB after learning that journalists were preparing to describe it as a floating AI data center. He dismissed this characterization as incomplete, asserting that the project is considerably older and “way cooler than that.”
In a spirited exchange with journalist Joshua Topolsky, Luckey offered a more specific glimpse into his ambitions. Topolsky questioned the practicality of establishing an offshore community for modernizing medical research, suggesting that regulatory reform could be achieved without constructing an island. He challenged Luckey to identify specific rules that had impeded his pursuit of medical advancements.
Luckey countered that he would prefer to create a space where individuals could “save their families with ‘safe but currently illegal medicine ASAP'” rather than await legislative reform. He accused political interests and major pharmaceutical companies of obstructing progress, arguing that conventional reform would necessitate legislation capable of garnering support from 60 senators.
Navigating Jurisdictional Complexities
Luckey’s plan also faces significant legal hurdles, as relocating operations to the ocean does not automatically place them outside American jurisdiction. When asked by an X user about SLAB’s proximity to San Francisco before falling under its jurisdiction, Luckey responded, “Three miles.”
This distance generally aligns with the boundary of California’s state-controlled coastal waters, according to the U.S. Bureau of Ocean Energy Management. However, federal jurisdiction extends much further. The United States maintains a 12-nautical-mile territorial sea and a 200-nautical-mile exclusive economic zone, where it exercises authority over certain economic activities and the construction and use of artificial islands, as per NOAA guidance.
The applicable legal framework would depend on SLAB’s precise location, whether it is a floating structure or fixed to the seabed, and its registration status. Even vessels operating on the high seas are subject to maritime laws and the jurisdiction of their flag states, suggesting that Luckey’s venture would not operate in a legal vacuum.
Medical research introduces its own set of complications. The FDA requires foreign clinical studies submitted for U.S. drug approvals to adhere to good clinical practice standards, including independent ethical review and informed consent. Conducting treatment offshore would not, in itself, legitimize the sale of unapproved drugs in the United States.
Past seasteading initiatives have encountered similar jurisdictional disputes. A floating community off Thailand led to a confrontation with authorities in 2019, while a subsequent project in Panama adopted boat registration to operate within an existing legal framework.
Currently, details regarding SLAB’s proposed location, the specific regulations it aims to circumvent, or the medical treatments it intends to offer remain undisclosed by Luckey. He has also not announced a construction timeline or provided independently verifiable information on the project’s physical development.
